Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Morphic Holding Inc (NQ: MORF ) 56.99 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Morphic Holding Inc < Previous 1 2 3 Next > Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses August 06, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders July 31, 2024 From Halper Sadeh LLC Via GlobeNewswire Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses July 29, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, COFS, PFC, WSBC on Behalf of Shareholders July 27, 2024 From Halper Sadeh LLC Via GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGR, MORF, DRQ, SHCR on Behalf of Shareholders July 24, 2024 From Halper Sadeh LLC Via GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, HUDA, ALE, DOMA on Behalf of Shareholders July 23, 2024 From Halper Sadeh LLC Via GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCR, MORF on Behalf of Shareholders July 20, 2024 From Halper Sadeh LLC Via GlobeNewswire MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF July 19, 2024 From Kahn Swick & Foti, LLC Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders July 11, 2024 From Halper Sadeh LLC Via GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, INFN, AMBC, BEST on Behalf of Shareholders July 10, 2024 From Halper Sadeh LLC Via GlobeNewswire MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF July 09, 2024 From Kahn Swick & Foti, LLC Via Business Wire Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion – InsideArbitrage July 09, 2024 Via AB Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, MORF, AGR on Behalf of Shareholders July 08, 2024 From Halper Sadeh LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR) July 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire MORF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Morphic Holding, Inc. Is Fair to Shareholders July 08, 2024 From Halper Sadeh LLC Via Business Wire Morphic to Participate in Jefferies Global Healthcare Conference May 31, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells May 21, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic to Participate in RBC Capital Markets Global Healthcare Conference May 09, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 April 25, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings April 02, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings March 26, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF) March 20, 2024 From Abraham, Fruchter & Twersky, LLP Via GlobeNewswire Morphic Appoints Dr. Simon Cooper as Chief Medical Officer March 19, 2024 Experienced Clinical Development Leader with Deep Experience in Immunology and Inflammatory Diseases From Morphic Therapeutic Via GlobeNewswire Morphic to Participate in March Investor Conferences March 05, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 February 22, 2024 From Morphic Therapeutic Via GlobeNewswire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 11, 2024 From Law Offices of Howard G. Smith Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 10, 2024 From Glancy Prongay & Murray LLP Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 04, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Morphic Therapeutic Via GlobeNewswire Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors December 01, 2023 From Robbins LLP Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
